Home > Healthcare > Biotechnology > Biopharma > Bioink Market

Bioink Market Share

  • Report ID: GMI9118
  • Published Date: Apr 2024
  • Report Format: PDF

Bioink Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical and biotechnology companies that involved in drug discovery and development vying for market share. Key players are engaging in strategic initiatives such as product launch, collaboration, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for bioink.
 

Bioink Market Companies

Prominent players operating in the bioink industry are as mentioned below:

  • CELLLINK
  • BIO INX BV
  • Advance BioMatrix
  • Allevi, Inc.
  • Essent Biologics
  • Merck KGaA
  • Rousselot
  • Jellagen
  • CollPlant
  • Foldink. Life science technology
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global bioink market was valued at USD 159.5 million in 2023 and will witness 18.1% CAGR during 2024-2032, driven by the increase in application in biomedical research and therapy, along with the rising incidence of chronic diseases.

Natural bioink industry size was USD 91.6 million in 2023, owing to unique properties like biocompatibility and nontoxicity which make them well adapted for several tissue engineering applications.

North America bioink market recorded 42.7% revenue share in 2023, attributed to the availability of technologically advanced bioink products like improved printing resolution, multi-material printing capabilities.

CELLLINK, BIO INX BV, Advance BioMatrix, Allevi, Inc., Essent Biologics, Merck KGaA, Rousselot, Jellagen, CollPlant Foldink, and Life science technology

Bioink Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 340
  • Countries covered: 22
  • Pages: 209
 Download Free Sample